Rigid Endoscopes Market - By Product (Laparoscopes, Arthroscopes, Cystoscopes, ENT Endoscopes), By Technology (Conventional Endoscopes, Video Endoscopes, Fiber-Optic Endoscopes), By Usability (Reusable Endoscopes, Disposable Endoscopes), By End-use & Forecast, 2023-2032

Rigid Endoscopes Market - By Product (Laparoscopes, Arthroscopes, Cystoscopes, ENT Endoscopes), By Technology (Conventional Endoscopes, Video Endoscopes, Fiber-Optic Endoscopes), By Usability (Reusable Endoscopes, Disposable Endoscopes), By End-use & Forecast, 2023-2032

Rigid Endoscopes Market Size

Rigid Endoscopes Market size was valued at around USD 9.1 billion in 2022 and is estimated to register over 6.6% CAGR between 2023 and 2032. The growing prevalence of chronic ailments coupled with the rising geriatric population is one of the key variables driving the industry growth. Endoscopy procedures that utilize rigid endoscopes are crucial in the management or treatment of multiple health conditions, including digestive tract-related infections, chronic obstructive pulmonary disease (COPD), and common ENT problems among others. According to the National Pancreas Foundation, chronic pancreatitis commonly develops in patients between the ages of 30 and 40 and is more prevalent in men than women.
 

Moreover, rising awareness regarding chronic disease diagnosis & treatment and a surging number of healthcare settings are set to prove conducive for business growth. Hence, owing to the above factors rising prevalence of chronic disorders is set to increase the demand for endoscopy procedures that will prove beneficial for business growth.
 

Furthermore, technological advancement is set to propel rigid endoscopes market growth during the forecast period. Advancement in endoscopic technologies results in an improvement in diagnosis, target disorders treatment, medical therapies, and other surgical devices. Leading industry players comprising Olympus Corporation is emphasizing introducing novel rigid endoscopes to deliver optimal operability for practitioners.
 

Developments in rigid video endoscopes design facilitate high-resolution imaging, great operability & bending capability, and enable effortless use. Hence, the commercialization of such advanced rigid endoscopes will accelerate business growth over the coming years. These advancements in fiberscope, video endoscope, use of nanotechnology for reduced inflammation & infection, and several other breakthroughs have surged the procedure result and success rate. As a result, the recent technological advancements are set to increase the demand for endoscopy procedures that will prove beneficial for the rigid endoscopes industry growth.
 

A rigid endoscope is a medical device used in various diagnostic and surgical procedures to visualize and examine the internal structures of the human body. It consists of a long, slender tube with a lens or an optical system at one end and an eyepiece or a camera attachment at the other end. The lens or optical system captures light and images from the target area inside the body and transmits them to the eyepiece or camera, allowing medical professionals to see the internal structures in real-time.
 

Limited flexibility associated with rigid endoscopes compared to flexible endoscopes may negatively impact business growth. Rigid endoscopes are typically designed for specific procedures and have a fixed field of view and angle. This limited versatility may lead to reduced adoption in a broader range of medical specialties or procedures, thus limiting their market potential. The rigid nature of these endoscopes can cause discomfort to patients during procedures, potentially leading to a negative perception of the medical facility and its equipment, that can impact customer satisfaction and retention. The limited applications and potential discomfort associated with rigid endoscopes may hinder their market growth potential. This, in turn, can impact revenue and profitability for companies that heavily rely on these devices.
 

COVID-19 Impact

The outbreak of COVID-19 had negatively impacted the rigid endoscopes industry revenue in 2020. The augmented demand for COVID-19 treatment has significantly impacted other disease treatments comprising endoscopy procedures. In 2020, the incidence, as well as the mortality rate due to coronavirus was highest and people preferred to avoid any other treatment procedures at healthcare facilities. The rate of endoscopy procedures reduced substantially during the COVID-impacted period worldwide. The U.S. declared a national emergency and a ban on all elective surgical procedures in outpatient and inpatient settings. Such variables had impacted the growth of the rigid endoscopes market in several countries across the globe. Due to rapidly increased coronavirus cases across the globe, hospitals and other healthcare facilities were consistently engaged in the treatment of coronavirus affected patients. Hence, this has led to the delay of various endoscopy procedures comprising gastrointestinal endoscopy across the globe.
 

However, in 2021, the technological advancements and incorporation of telemedicine have augmented target disease diagnosis and treatment compliance and promoted the acceptance of rigid endoscopes. In addition, some of the endoscopy procedures if not performed on time may lead to the death of patients. Hence, despite the coronavirus crisis, such emergency procedures were performed in healthcare facilities across the world. Moreover, as the number of COVID-19 affected patients reduce in several countries globally, the healthcare facilities were providing surgical care that had increased the number of endoscopies and is steadily restoring the procedural volume to the pre-pandemic level. These factors are helping to uplift the market growth. Thus, the COVID-19 pandemic has slightly affected the rigid endoscopes market in the shorter run; however, the declining COVID-19 infection rates & patients and rising procedural volume are set to facilitate the market growth in the coming years.
 

Rigid Endoscopes Market Trends

The growing popularity of minimally invasive therapies has had a significant impact on the growth and utilization of rigid endoscopes. Surging prevalence of chronic disorders across the globe  have led to a rise in surgical intervention, thereby propelling the demand for minimally invasive treatment incorporating the use of rigid endoscopy devices. The implementation of these devices for chronic disease treatment offers better patient compliance as well as aids in delivering optimal outcomes. Reduced surgical complications, rapid recovery, shorter stay in the hospitals, and effective management of postsurgical pain are the factors accelerating the demand for minimally invasive treatments, thereby driving the growth of the rigid  endoscopes market worldwide.
 

Ongoing advancements have favoured the evolution of endoscopy procedures that are associated with a less invasive nature in the treatment of chronic ailments. The emergence of the Enhanced recovery after surgery (ERAS) initiative for utilizing multimodal interventions during the perioperative period to facilitate faster recovery will promote the preference for less invasive surgeries among patients. Moreover, the rising preference and awareness pertaining to minimally invasive surgical techniques among the exponentially growing aging population in the region are expected to augment the market growth. Thus, owing to the aforementioned factors, the surge in demand for minimally invasive surgeries is anticipated to propel the market expansion positively.
 

Rigid Endoscopes Market Analysis

Based on product, the rigid endoscopes market is segmented as laparoscopes, arthroscopes, cystoscopes, ENT endoscopes, pulmonary endoscopes, and others. The laparoscopes segment held the dominant market share in 2022 and was valued at over USD 3.3 billion. This largest business share is majorly attributable to the surging prevalence of chronic ailments and increasing patient volume suffering from abdominal pain. Rigid laparoscopes are used to diagnose and treat acute & chronic abdominal pain. Appendicitis, intra-abdominal scar tissue, pelvic infections, endometriosis, abdominal haemorrhage, and other severe diseases require laparoscopy.
 

Endometriosis is one of the leading causes of abdominal pain among women that requires laparoscopy. For instance, according to the reports published by the World Health Organization (WHO), in 2021, around 190 million females globally suffered from endometriosis that accounted for around 10% of the female population. The rising prevalence of such conditions is expected to drive the visits at hospitals & ambulatory surgical centers for diagnosis & treatment. Therefore, the demand for laparoscopic instruments is expected to grow at a steady pace due to aging population and rising incidences of gastrointestinal disorders. Thus, the rising prevalence along with aging population is set to drive the patient volume in healthcare settings, thereby boosting the demand for rigid laparoscope significantly.
 

Based on technology, the rigid endoscopes market is segmented as conventional endoscopes, video endoscopes, and fiber-optic endoscopes. The video endoscopes segment accounted for a dominant market share in 2022 and was valued at over USD 5.0 billion. This high market share is owing to increasing demand and surging awareness pertaining to advantages delivered by rigid video endoscopes in the early-stage diagnosis of multiple chronic health conditions comprising stomach pain, ulcers, gastritis, digestive tract bleeding, etc. These rigid video endoscopes are highly used in endoscopy procedures as it enables endoscopic examination of the esophagus and offers a mobile & convenient solution for hospitals among others.
 

The video endoscopes are intended to aid the physicians or endoscopists for diagnostic & therapeutic procedures in endoscopy, endotracheal intubation, etc. The increasing prevalence of liver diseases such as gastroesophageal reflux disorder (GERD), biliary disease, and Crohn’s disease among others is stimulating the adoption of these products. For instance, as per the recent data, around 5.5 million people in the U.S. have chronic liver disease or cirrhosis. Furthermore, rising awareness related to devices used in endoscopy procedures for the treatment of these diseases assists in boosting business growth. As a result, several clinical advantages delivered by the rigid video endoscope are projected to fuel the market growth positively.
 

Based on usability, the rigid endoscopes market is segmented as reusable endoscopes and disposable endoscopes. The disposable rigid endoscopes segment held a notable market share in 2022 and was valued at around USD 2.9 billion. The rising demand for disposable rigid endoscopes in various healthcare facilities including hospitals, ACSs, and clinics is set to accelerate the segmental growth. These products are single use rigid endoscopes and discarded immediately after use. Disposable endoscopes curb cross-contamination with patients and practitioners, thereby preventing the spread of pathogenic microbes and other infection from external sources. These products are highly advantageous and also protect against a set of threats, including biohazards, pathogens such as bacteria and viruses, and other chemicals.
 

Furthermore, increasing awareness regarding health safety along with growing number of surgeries are further fostering the demand for disposable rigid endoscopes. Therefore, the aforementioned factors are set to influence the demand for disposable rigid endoscopes and expected to witness lucrative growth in rigid endoscopes industry in the coming years.
 

Based on end-use, the rigid endoscopes market is segmented as hospitals, ambulatory surgical centers, clinics, Others. The hospitals segment is projected to reach more than USD 7.7 billion by 2032. This majority market share is owing to the soaring use of novel rigid endoscopes in hospital settings offering enhanced operability is estimated to surge the patient preference for hospitals. Increasing admissions with target disorders due to sedentary lifestyle and growing disease screening initiatives coupled with the availability of highly skilled healthcare professionals are some other attributes that are propelling the growth of the hospitals segment positively.
 

Additionally, the higher chronic disease incidence in developed nations with robust healthcare infrastructure is anticipated to positively impact the segment growth. Surging cancer cases, infections, and metabolic disease prevalence will significantly propel the diagnosis & treatment rate at hospitals. Thus, accessibility to better treatment & diagnosis coupled with the rising prevalence of these ailments and associated conditions is estimated to boost patient visits to hospitals, thereby propelling the segment revenue.
 

U.S. dominated the North America rigid endoscopes market with a significant market share in 2022 and is anticipated to expand at a considerable pace to reach around USD 6.7 billion by 2032. This significant market share is attributable to several factors such as the presence of major business players, surging demand for the product, etc. The presence of prominent players such as Boston Scientific Corporation, Olympus Corporation, and Karl Storz among others are engaged in the new product development & commercialization that facilitates the industrial expansion in the country. The high prevalence of gastrointestinal diseases and the rising hospital admission in the region emphasize the growing need for rigid endoscopes in related procedures. As per the National Ambulatory Medical Care recent survey, over 40 million patients had performed diagnosis for diseases of the digestive systems in the U.S.
 

Rigid Endoscopes Market Share

Some of the major market players operating in the rigid endoscopes market are

• B Braun Melsungen AG,
• Boston Scientific Corporation
• Conmed Corporation
• Cook Medical
• Ethicon
• Fujifilm Holdings Corporation among others.

Major market players are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations to garner maximum industry share and promote company growth.
 

Rigid Endoscopes Industry News

• In November 2021, Medtronic plc, announced that their PillCam Small Bowel 3 system had received the U.S. Food and Drug Administration (FDA) 510(k) clearance for remote endoscopy procedures. This device provides a telehealth option for direct visualization and monitoring of the small bowel, and better detection of lesions. This FDA clearance helped the company to enhance their R&D capabilities and increase their business revenue.
   
• In January 2020, Cook Medical introduced Instinct Plus, an endoscopic clipping device made compatible for duodenoscopes in the U.S. The device is made for smoother operation and responsive handling. This launch helped the company to strengthen its already existing robust endoscope portfolio.
   

Rigid endoscopes market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (million) and volume (Units) from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Product

• Laparoscopes
• Arthroscopes
• Cystoscopes
• ENT Endoscopes
• Pulmonary Endoscopes
• Others

By Technology

• Conventional Endoscopes
• Video Endoscopes
• Fiber-Optic Endoscopes

By Usability

• Reusable Endoscopes
• Disposable  Endoscopes

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Switzerland
  • The Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Iran
  • Turkey